Otsuka Pharmaceutical Co.’s medicine for post-traumatic stress disorder with partner H. Lundbeck A/S failed to win the backing of US regulatory advisers, a major setback in the drugmakers’ bid to ...

FDA reviewers flag "discordant results" in a briefing document published ahead of Friday's advisory committee meeting for the ...

University of Leeds psychologists report that stress appraisal and perceived stress act as key conduits linking childhood ...

Kodiak Harbormaster and Borough Assemblyman Dave Johnson is back on the job after spending the past six weeks in therapy for ...

Otsuka Pharma (OTCPK:OTSKY) and H. Lundbeck (OTCPK:HLBBF) draws efficacy concerns for their PTSD therapy from the FDA ahead ...

Data suggest that OSA diagnoses were associated with an increased risk for physical and psychological problems in active-duty ...

Within months of Pennsylvania's medical cannabis program adding anxiety as a qualifying condition, that diagnosis quickly ...

Adding anxiety disorders as a qualifying condition for medical cannabis in Pennsylvania was associated with an increase in certifications.

A boy charged with manslaughter and other crimes after accidentally shooting and killing his 15-year-old cousin will no ...

Since being added as a qualifying condition in 2019, the mental health disorder accounts for 60% of all license ...

Post-Traumatic Stress Disorder (PTSD) is a psychiatric condition triggered by experiencing or witnessing a traumatic event.

A controversial treatment offers a painless route to ridding veterans of their trauma responses. But does it really work?